Why Artiman returned to lead CellMax's $9M A-1 round

—  Disrupting detection  — Virginia Li –  BioCentury – Monday, August 1, 2016  – Following the validation and Taiwan launch of CRC-Protect, CellMax Life Inc. has convinced Artiman Ventures to return for seconds and lead a $9 million series A-1 round. The funding will enable the California company to develop the blood-based colorectal cancer...

CellMax Life launches cancer detection blood tests

– PREVENTATIVE:  After being screened with one of the firm's products, a woman said she agreed to have surgery that removed eight polyps and reduced her risk of cancer – Ted Chen — The Taipei Times — July 27, 2016 — CellMax Life Inc (合度精密生物科技) yesterday launched a blood-testing service in Taiwan that focuses on screening for early-stage cancer....

OncoStem in ABSICON 2016

July 01, 2016
OncoStem in ABSICON 2016

OncoStem Diagnostics participated in ABSICON 2016, a Breast Cancer focused surgical oncology meeting held from July 1st-3rd at Hotel ITC Gardenia, Bangalore. Dr. Manjiri Bakre gave an invited lecture on the development and validation of CanAssist-Breast and its utility in patients with Breast Cancer. OncoStem Diagnostics also had a booth at...

Khush F. Mehta Joins CardioDx as Chief Executive Officer

– Seasoned Healthcare Executive Appointed to Lead Company Growth –   REDWOOD CITY, Calif. – June 1, 2016 – CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today the appointment of Khush Mehta as President, Chief Executive Officer, and a member of the Board of Directors of CardioDx. With a proven...

Artiman Ventures Announces 2016 B.E.T.A. Class

– Venture capital firm provides pathway to Silicon Valley for aspiring student entrepreneurs with backgrounds in Biology, Economics, Technology, and the Arts – PALO ALTO, Calif. – April 21, 2016 – Artiman Ventures announced today members of its 2016 B.E.T.A. program. The program connects students with backgrounds in Biology, Economics, Technology...

Pages